Company Filing History:
Years Active: 2025
Title: Chunyin Marshall Law: Innovator in KRAS Inhibition
Introduction
Chunyin Marshall Law is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target KRAS activity. His work is crucial in the fight against diseases associated with this challenging oncogene.
Latest Patents
Chunyin holds a patent for "Tricyclic compounds as inhibitors of KRAS." This patent discloses compounds of Formula I, which are designed to inhibit KRAS activity. The compounds are particularly useful in treating, preventing, or ameliorating diseases or disorders linked to KRAS activity, such as cancer. He has 1 patent to his name, showcasing his innovative approach to addressing critical health issues.
Career Highlights
Chunyin is currently employed at Incyte Corporation, a leading biopharmaceutical company. His role involves research and development focused on creating effective treatments for cancer and other serious diseases. His expertise and dedication have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Chunyin has collaborated with talented coworkers, including Pei Gan and Jeffrey Yang. Their combined efforts contribute to the advancement of research and the development of new therapeutic strategies.
Conclusion
Chunyin Marshall Law's work in developing KRAS inhibitors represents a significant advancement in cancer treatment. His innovative spirit and dedication to research continue to inspire progress in the pharmaceutical field.